 HIV
"HIV" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Descriptor ID |
D006678
|
| MeSH Number(s) |
B04.820.650.589.650.350 B04.909.777.731.589.650.350
|
| Concept/Terms |
HIV- HIV
- Viruses, Human Immunodeficiency
- AIDS Virus
- AIDS Viruses
- Virus, AIDS
- Viruses, AIDS
- HTLV-III
- Human Immunodeficiency Virus
- Human Immunodeficiency Viruses
- Human T Cell Lymphotropic Virus Type III
- Human T Lymphotropic Virus Type III
- Human T-Cell Leukemia Virus Type III
- Human T Cell Leukemia Virus Type III
- Human T-Cell Lymphotropic Virus Type III
- Human T-Lymphotropic Virus Type III
- Immunodeficiency Virus, Human
- Immunodeficiency Viruses, Human
- LAV-HTLV-III
- Lymphadenopathy-Associated Virus
- Lymphadenopathy Associated Virus
- Lymphadenopathy-Associated Viruses
- Virus, Lymphadenopathy-Associated
- Viruses, Lymphadenopathy-Associated
- Virus, Human Immunodeficiency
- Acquired Immune Deficiency Syndrome Virus
- Acquired Immunodeficiency Syndrome Virus
|
Below are MeSH descriptors whose meaning is more general than "HIV".
Below are MeSH descriptors whose meaning is more specific than "HIV".
This graph shows the total number of publications written about "HIV" by people in this website by year, and whether "HIV" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 1 | 0 | 1 | | 1992 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 1 | 2 | | 2002 | 1 | 0 | 1 | | 2003 | 1 | 2 | 3 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 2 | 4 | | 2013 | 0 | 1 | 1 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 1 | 2 | | 2017 | 2 | 3 | 5 | | 2018 | 1 | 2 | 3 | | 2019 | 1 | 3 | 4 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "HIV" by people in Profiles.
-
Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021 02; 8(2):e114-e120.
-
Lipira L, Williams EC, Huh D, Kemp CG, Nevin PE, Greene P, Unger JM, Heagerty P, French AL, Cohn SE, Turan JM, Mugavero MJ, Simoni JM, Andrasik MP, Rao D. HIV-Related Stigma and Viral Suppression Among African-American Women: Exploring the Mediating Roles of Depression and ART Nonadherence. AIDS Behav. 2019 Aug; 23(8):2025-2036.
-
Kotila OA, Fawole OI, Olopade OI, Ayede AI, Falusi AG, Babalola CP. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians. Pharmacogenet Genomics. 2019 07; 29(5):106-113.
-
Korobchuk A, Davtyan H, Denisiuk O, Zachariah R, Nikolopoulos GK, Paraskevis D, Skaathun B, Schneider J, Vasylyeva TI, Williams LD, Smyrnov P, Friedman SR. People with high HIV viral load within risk networks: who are these people and who refers them best? J Infect Dev Ctries. 2019 07; 13(7 Suppl):103S-110S.
-
Bibollet-Ruche F, Russell RM, Liu W, Stewart-Jones GBE, Sherrill-Mix S, Li Y, Learn GH, Smith AG, Gondim MVP, Plenderleith LJ, Decker JM, Easlick JL, Wetzel KS, Collman RG, Ding S, Finzi A, Ayouba A, Peeters M, Leendertz FH, van Schijndel J, Goedmakers A, Ton E, Boesch C, Kuehl H, Arandjelovic M, Dieguez P, Murai M, Colin C, Koops K, Speede S, Gonder MK, Muller MN, Sanz CM, Morgan DB, Atencia R, Cox D, Piel AK, Stewart FA, Ndjango JN, Mjungu D, Lonsdorf EV, Pusey AE, Kwong PD, Sharp PM, Shaw GM, Hahn BH. CD4 receptor diversity in chimpanzees protects against SIV infection. Proc Natl Acad Sci U S A. 2019 02 19; 116(8):3229-3238.
-
Tsikis S, Hoefer L, Bethimoutis G, Nicolaidou E, Paparizos V, Antoniou C, Chardalias L, Stavropoulos GE, Sharma S, Long BC, Mujacic I, Kadri S, Segal JP, Furtado LV, Schneider J, Charnot-Katsikas A. Risk factors, prevalence, and site concordance of human papillomavirus in high-risk Greek men. Eur J Cancer Prev. 2018 09; 27(5):514-520.
-
Friedman SR, Williams L, Young AM, Teubl J, Paraskevis D, Kostaki E, Latkin C, German D, Mateu-Gelabert P, Guarino H, Vasylyeva TI, Skaathun B, Schneider J, Korobchuk A, Smyrnov P, Nikolopoulos G. Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics. Curr HIV/AIDS Rep. 2018 06; 15(3):283-292.
-
Belkin MN, Uriel N. Heart health in the age of highly active antiretroviral therapy: a review of HIV cardiomyopathy. Curr Opin Cardiol. 2018 05; 33(3):317-324.
-
Vieira MC, Zinder D, Cobey S. Selection and Neutral Mutations Drive Pervasive Mutability Losses in Long-Lived Anti-HIV B-Cell Lineages. Mol Biol Evol. 2018 05 01; 35(5):1135-1146.
-
Kankanala J, Kirby KA, Huber AD, Casey MC, Wilson DJ, Sarafianos SG, Wang Z. Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. Eur J Med Chem. 2017 Dec 01; 141:149-161.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|